Log In
BCIQ
Print this Print this
 

THVD-202

  Manage Alerts
Collapse Summary General Information
Company TheraVida Inc.
DescriptionOnce-daily formulation of tolterodine and pilocarpine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPreclinical
Standard IndicationIncontinence
Indication DetailsTreat overactive bladder (OAB) and urge urinary incontinence
Regulatory Designation
PartnerSK Chemicals Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/08/2013

Undisclosed

0

Undisclosed

Get a free BioCentury trial today